Cell cycle inhibitors (p27Kip1 and p21CIP1) cause hypertrophy in LLC-PK1 cells
- 1 August 1999
- journal article
- Published by Elsevier in Kidney International
- Vol. 56 (2), 494-501
- https://doi.org/10.1046/j.1523-1755.1999.00568.x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Cyclin D1, p16, and retinoblastoma gene regulate mitogenic signaling of endothelin in rat mesangial cellsKidney International, 1998
- Angiotensin II-stimulated hypertrophy of LLC-PK1 cells depends on the induction of the cyclin-dependent kinase inhibitor p27Kip1Kidney International, 1996
- Cancer Cell CyclesScience, 1996
- Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibitionNature, 1995
- Inhibitors of mammalian G1 cyclin-dependent kinases.Genes & Development, 1995
- Cyclins and cancer II: Cyclin D and CDK inhibitors come of ageCell, 1994
- p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21Cell, 1994
- Cloning of Senescent Cell-Derived Inhibitors of DNA Synthesis Using an Expression ScreenExperimental Cell Research, 1994
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993